What is the Best Way to Treat Patients with Raynaud’s Phenomenon and a Tendency towards Hypotension?

Autor: Helena Drobek, Hanna, Porwolik, Mateusz, Pietrauszka, Kornelia, Miziołek, Bartosz, Bergler-Czop, Beata, Brzezińska-Wcisło, Ligia
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Acta Dermatovenerologica Croatica
Volume 28
Issue 3
ISSN: 1847-6538
1330-027X
Popis: Episodes of excessive vasospasm are common in patients with Raynaud’s phenomenon (RP). Pharmacological treatment may often result in side-effects such as hypotension, leading to discontinuation of treatment. Review of therapeutic interventions with regard to tendency towards hypotension was done in medical databases including PubMed, Scopus, and Medline to summarize the current state of the knowledge. Despite the episodes of blood pressure drops caused by hypotension, calcium channel blockers (CCB) have been widely used in RP as first-line treatment medication. The use of other CCB apart from nifedipine is controversial due to the variety of results in clinical trials. A clinical study comparing the efficacy and tolerability of losartan with nifedipine revealed a significant reduction in RP severity, frequency of episodes, and reported adverse effects. Application of oral sildenafil 100 mg/d as an add-on therapy increased microvascular blood flow in secondary RP, while being welltolerated and with no withdrawal from the study. Topical vasodilators may be applied as an adjuvant therapy for patients with RP. Clinical studies approved 10% nifedipine cream and 10% nitroglycerine gel as an efficient RP therapy with side-effects comparable with placebo usage. Non-pharmacological interventions, such as cold avoidance, stress management, and smoking cessation are recommended in reducing episodes of RP. Calcium channel blockers, with a particular emphasis on nifedipine, in combination with non-pharmacological management seem to be the optimal way to treat the patients with a tendency to hypotension
Databáze: OpenAIRE
Externí odkaz: